Additional information
| Active substance | Triiodothyronine |
|---|---|
| Trade name | Aggrastat |
| Side effects | Bleeding, thrombocytopenia, back pain, fever, nausea, headache, and dizziness |
| Effects | Reduces the aggregation of platelets, thus preventing thrombosis |
| Dosage (sports) | Not applicable as it is not used for sports enhancement |
| Dosage (medical) | Typically, an initial bolus dose of 0.4 micrograms per kilogram per minute for 30 minutes followed by a continuous infusion of 0.1 micrograms per kilogram per minute |
| Half-life | Approximately 1.5 to 2 hours |
| Main action | Antiplatelet agent |
| Substance class | Glycoprotein IIb/IIIa inhibitor |
| Formula | C22H36N4O5S |
| Chemical name | N-(butylsulfonyl)-4-(4-(4-piperidinyl)butyl)phenyl-2,5-dihydropyridazin-3-amine |
| Storage conditions | Store at controlled room temperature, away from moisture and heat |
| Blood pressure | May cause transient hypotension |
| WAREHOUSE | International Warehouse 3 |
| Also known as | MK-383 |
| Lab Test | Coagulation parameters and platelet counts may be monitored |
| Aromatization | No |
| Hepatotoxicity | No |
| HBR | Yes |
| Water Retention | No |
| Acne | No |
| Dosage | 25-75 mcg/day |
| Classification | Thyroid hormone |
| Active Half-Life | 1 day |
| Use in sports | None |
| Manufacturer | Pharmacom Labs |
Reviews
There are no reviews yet.